From April 25 to 30, local time in the United States, the top event in the global oncology community, the 2025 American Association for Cancer Research (AACR) Annual Meeting, was held grandly at the McCormick Place in Chicago.
Ms. Grace Song, General Manager of Lianke Bio, led the team to cross the Sino-US trade barriers and represented the company on this international stage, showing the innovative resilience and technological achievements of Chinese biotechnology companies to the global scientific research community. During the exhibition, Lianke Bio set up a main product exhibition area, focusing on displaying our company's main ELISA kits, flow antibodies, and flow detection kits, and attracted many scientific research institutions, clinical experts and corporate representatives to stop and communicate with excellent quality and high cost-effectiveness.
The American Association for Cancer Research (AACR) was founded in 1907 and is the oldest and largest cancer research organization in the world. Its members are all over the world, including 56 Nobel Prize winners, and have a wide and authoritative influence. The AACR Annual Meeting is held in April every year and is also one of the largest and most influential academic conferences in the field of cancer research in the world. The purpose is to improve the prognosis and quality of life of cancer patients by promoting cancer scientific research, promoting interdisciplinary cooperation and accelerating the transformation of scientific research results into clinical applications. The annual meeting provides a platform for cancer researchers, clinicians, pharmaceutical company representatives from all over the world to exchange the latest research progress, share experiences and explore cooperation opportunities.
